About This Fund
The Northleaf Growth Fund (NGF) is a direct growth equity fund that focuses on technology and healthcare sectors. The fund targets growth-stage companies in North America through a combination of direct co-investments and opportunistic secondary transactions. It aims to provide investors with access to a diversified portfolio of high-potential, innovative companies in partnership with leading fund managers. The Fund’s strategy targets growth-stage companies in North America through a combination of direct co-investments and opportunistic secondary transactions, which have been key contributors to Northleaf’s established growth equity track record. The company has a 15-year track record in venture capital/growth equity and has supported companies such as BlueCat Networks, eSentire, Verafin, and Zymeworks. With a total capital commitment exceeding US$24 billion, Northleaf's global private equity and venture capital/growth equity program has raised more than US$13 billion to date and serves more than 140 institutional and family office investors across North America, the UK/EMEA, and Asia. The focus on mid-market companies and assets reflects Northleaf's emphasis on sourcing, evaluating, and managing private markets investments. For more information on Northleaf, please visit www.northleafcapital.com.